Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred Witjes

Showing results (71-80 of 378) with videos related to

Pageof 38
Sort By:
The Urologic Clinics of North America|April 2, 2013
NMIBC risk calculators: how useful are they for the practicing urologist and how can their clinical utility be improved?Rianne J M Lammers, Richard J Sylvester, Cheryl T Lee, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?Günter Niegisch, Christina Hulsbergen-van de Kaa, Martine Ploeg, et al.
World Journal of Urology|June 19, 2007
The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysisAntoine G van der Heijden, Christina A Hulsbergen-Van de Kaa, J Alfred Witjes
Current Opinion in Urology|June 21, 2021
Patient-reported outcomes and health-related quality of life after urinary diversionsSiberyn T Nuijens, Hanny Cobussen-Boekhorst, John P F A Heesakkers, et al.
Urologic Oncology|March 15, 2011
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladderSeth P Lerner, Hao Liu, Meng-Fen Wu, et al.
The Journal of Urology|June 11, 2005
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trialsRichard J Sylvester, Adrian P M van der Meijden, J Alfred Witjes, et al.
European Urology|August 27, 2013
Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection?Ansje S Fortuin, Hanneke Meijer, Les C Thompson, et al.
European Urology|March 4, 2011
Advances in magnetic resonance imaging: how they are changing the management of prostate cancerAlessandro Sciarra, Jelle Barentsz, Anders Bjartell, et al.
World Journal of Urology|May 17, 2018
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat modelJohannes Falke, Christina A Hulsbergen-van de Kaa, Roberto Maj, et al.
Urology|April 29, 2014
Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing dataJ Alfred Witjes, Leonard G Gomella, Arnulf Stenzl, et al.
Pageof 38

Showing results (71-80 of 378) with videos related to

Sort By:
Pageof 38
The Urologic Clinics of North America|April 2, 2013
NMIBC risk calculators: how useful are they for the practicing urologist and how can their clinical utility be improved?Rianne J M Lammers, Richard J Sylvester, Cheryl T Lee, et al.
Bladder Cancer (Amsterdam, Netherlands)|December 19, 2018
Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?Günter Niegisch, Christina Hulsbergen-van de Kaa, Martine Ploeg, et al.
World Journal of Urology|June 19, 2007
The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysisAntoine G van der Heijden, Christina A Hulsbergen-Van de Kaa, J Alfred Witjes
Current Opinion in Urology|June 21, 2021
Patient-reported outcomes and health-related quality of life after urinary diversionsSiberyn T Nuijens, Hanny Cobussen-Boekhorst, John P F A Heesakkers, et al.
Urologic Oncology|March 15, 2011
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladderSeth P Lerner, Hao Liu, Meng-Fen Wu, et al.
The Journal of Urology|June 11, 2005
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trialsRichard J Sylvester, Adrian P M van der Meijden, J Alfred Witjes, et al.
European Urology|August 27, 2013
Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection?Ansje S Fortuin, Hanneke Meijer, Les C Thompson, et al.
European Urology|March 4, 2011
Advances in magnetic resonance imaging: how they are changing the management of prostate cancerAlessandro Sciarra, Jelle Barentsz, Anders Bjartell, et al.
World Journal of Urology|May 17, 2018
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat modelJohannes Falke, Christina A Hulsbergen-van de Kaa, Roberto Maj, et al.
Urology|April 29, 2014
Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing dataJ Alfred Witjes, Leonard G Gomella, Arnulf Stenzl, et al.
Pageof 38